- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Markets
Stocks
F&O
Mutual Funds
- More
Open Free Demat Account
Scheme Information
Edelweiss MSCI India D&W HC 45 RegIDCW-T
as of 21 May 2026, 09:36 AM
Scheme Asset Size₹174.93 Cr
Expense Ratio1.06%
Cash Holding0.32093%
Fund TypeOpen-End
PlanDividend
BenchmarkMSCI Ind Dom & Wld HealthC 45 NR INR
Launch Date2020-10-26
Exit LoadExit load of 0.00% for investments if redeemed within 1 Months
SIP Calculator
12%
₹5,000
₹500₹10,00,000
10 Years
1 Year40 Years
Invested Amount
Estimated Return
Invested Amount
₹6,00,000
Est. Return
₹5,61,695
Total Value
₹11,61,695
Invested Amount
Estimated Return
Scheme Ratings
-
rated by Value Research
Scheme Riskometer
Your principal will be at Very High Risk
Investment Returns
Absolute Returns
CAGR
In the last 1 months -4.78%
In the last 3 months -3.89%
In the last 6 months 1.15%
In the last 1 Years 3.82%
In the last 3 Years 0.75%
In the last 5 Years 0.90%
Company Holdings
Company Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | Healthcare | E | 11.25% |
| Eli Lilly and Co | Healthcare | E | 6.01% |
| Max Healthcare Institute Ltd Ordinary Shares | Healthcare | E | 5.73% |
| Apollo Hospitals Enterprise Ltd | Healthcare | E | 5.69% |
| Divi's Laboratories Ltd | Healthcare | E | 5.17% |
| Cipla Ltd | Healthcare | E | 5.14% |
| Dr Reddy's Laboratories Ltd | Healthcare | E | 4.71% |
| Johnson & Johnson | Healthcare | E | 4.25% |
| Lupin Ltd | Healthcare | E | 3.90% |
| Torrent Pharmaceuticals Ltd | Healthcare | E | 3.46% |
| Fortis Healthcare Ltd | Healthcare | E | 3.12% |
| AbbVie Inc | Healthcare | E | 2.91% |
| Laurus Labs Ltd | Healthcare | E | 2.55% |
| Novartis AG ADR | Healthcare | E | 2.28% |
| Glenmark Pharmaceuticals Ltd | Healthcare | E | 2.24% |
| Merck & Co Inc | Healthcare | E | 2.20% |
| Aurobindo Pharma Ltd | Healthcare | E | 2.15% |
| Mankind Pharma Ltd | Healthcare | E | 1.88% |
| Alkem Laboratories Ltd | Healthcare | E | 1.82% |
| Amgen Inc | Healthcare | E | 1.48% |
| Ipca Laboratories Ltd | Healthcare | E | 1.44% |
| Abbott Laboratories | Healthcare | E | 1.42% |
| Biocon Ltd | Healthcare | E | 1.41% |
| Thermo Fisher Scientific Inc | Healthcare | E | 1.37% |
| Gilead Sciences Inc | Healthcare | E | 1.31% |
| Intuitive Surgical Inc | Healthcare | E | 1.27% |
| Zydus Lifesciences Ltd | Healthcare | E | 1.25% |
| Aster DM Healthcare Ltd Ordinary Shares | Healthcare | E | 1.03% |
| Danaher Corp | Healthcare | E | 0.95% |
| Stryker Corp | Healthcare | E | 0.94% |
| Gland Pharma Ltd | Healthcare | E | 0.91% |
| Vertex Pharmaceuticals Inc | Healthcare | E | 0.90% |
| Medtronic PLC | Healthcare | E | 0.89% |
| Narayana Hrudayalaya Ltd | Healthcare | E | 0.88% |
| Ajanta Pharma Ltd | Healthcare | E | 0.88% |
| Novo Nordisk AS ADR | Healthcare | E | 0.86% |
| GlaxoSmithKline Pharmaceuticals Ltd | Healthcare | E | 0.73% |
| Piramal Pharma Ltd | Healthcare | E | 0.63% |
| Global Health Ltd | Healthcare | E | 0.62% |
| Regeneron Pharmaceuticals Inc | Healthcare | E | 0.58% |
| Syngene International Ltd | Healthcare | E | 0.52% |
| Becton Dickinson & Co | Healthcare | E | 0.36% |
| Agilent Technologies Inc | Healthcare | E | 0.24% |
| IQVIA Holdings Inc | Healthcare | E | 0.21% |
| Illumina Inc | Healthcare | E | 0.14% |
| Net Receivables/(Payables) | - | CA | 0.17% |
| Clearing Corporation Of India Ltd. | - | CR | 0.15% |
| Accrued Interest | - | CA | 0.00004% |
Sector Holding Analysis
Equity / Debt / Cash Split
Loading chart…
Equity
99.68%
Cash
0.32%
Equity sector allocation
Loading chart…
Healthcare
99.68%
Others
0.32%
Fund House Contact Details
Websitewww.edelweissmf.com
Phone+91 22 40979900
Edelweiss Asset Management Limited
Asset Management Company
Funds in this Category
Nippon India Taiwan Equity Reg Gr
Equity
Min. Investment
₹500
Category Returns
31.96%
63.78%
3Y Returns
+63.78%
Mirae Asset NYSE FANG+ ETF FoF Reg Gr
Equity
Min. Investment
₹5000
Category Returns
31.96%
63.78%
3Y Returns
+48.34%
DSP Wld Gld Mng Ovrs Eq Omni FoF Gr
Equity
Min. Investment
₹100
Category Returns
31.96%
63.78%
3Y Returns
+45.98%
About Edelweiss MSCI India D&W HC 45 RegIDCW-T
Investment Objective of the Scheme
The Scheme will invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. However, there is no assurance that the investment objective of the Scheme will be realized and the Scheme does not assure or guarantee any returns.
Key Features of The Fund
5-year return
+13.64%
Fund Manager
Bhavesh Jain
Risk Profile
Very High Risk
Expense Ratio
1.06%
Fund Size
₹174.93 Cr
FAQ's
What has been the returns generated by Edelweiss MSCI India D&W HC 45 RegIDCW-T over different time periods?
The Edelweiss MSCI India D&W HC 45 RegIDCW-T has given returns
1-Year
3.82
3-Year
20.49
5-Year
13.64
What is the expense ratio of Edelweiss MSCI India D&W HC 45 RegIDCW-T?
The expense ratio of Edelweiss MSCI India D&W HC 45 RegIDCW-T is 1.06%.
What is the AUM (Assets Under Management) of Edelweiss MSCI India D&W HC 45 RegIDCW-T?
The AUM, short for Assets Under Management of Edelweiss MSCI India D&W HC 45 RegIDCW-T is ₹174.93 Cr as of 07 Jun 2025.
What are the top stock holdings of Edelweiss MSCI India D&W HC 45 RegIDCW-T?
The Edelweiss MSCI India D&W HC 45 RegIDCW-T has invested the majority of its money in the stocks of the following companies:
| Company | Percentage of Portfolio |
|---|---|
| Sun Pharmaceuticals Industries Ltd | 11.25% |
| Eli Lilly and Co | 6.01% |
| Max Healthcare Institute Ltd Ordinary Shares | 5.73% |
| Apollo Hospitals Enterprise Ltd | 5.69% |
| Divi's Laboratories Ltd | 5.17% |
| Cipla Ltd | 5.14% |
| Dr Reddy's Laboratories Ltd | 4.71% |
| Johnson & Johnson | 4.25% |
| Lupin Ltd | 3.90% |
| Torrent Pharmaceuticals Ltd | 3.46% |
| Fortis Healthcare Ltd | 3.12% |
| AbbVie Inc | 2.91% |
| Laurus Labs Ltd | 2.55% |
| Novartis AG ADR | 2.28% |
| Glenmark Pharmaceuticals Ltd | 2.24% |
| Merck & Co Inc | 2.20% |
| Aurobindo Pharma Ltd | 2.15% |
| Mankind Pharma Ltd | 1.88% |
| Alkem Laboratories Ltd | 1.82% |
| Amgen Inc | 1.48% |
| Ipca Laboratories Ltd | 1.44% |
| Abbott Laboratories | 1.42% |
| Biocon Ltd | 1.41% |
| Thermo Fisher Scientific Inc | 1.37% |
| Gilead Sciences Inc | 1.31% |
| Intuitive Surgical Inc | 1.27% |
| Zydus Lifesciences Ltd | 1.25% |
| Aster DM Healthcare Ltd Ordinary Shares | 1.03% |
| Danaher Corp | 0.95% |
| Stryker Corp | 0.94% |
| Gland Pharma Ltd | 0.91% |
| Vertex Pharmaceuticals Inc | 0.90% |
| Medtronic PLC | 0.89% |
| Narayana Hrudayalaya Ltd | 0.88% |
| Ajanta Pharma Ltd | 0.88% |
| Novo Nordisk AS ADR | 0.86% |
| GlaxoSmithKline Pharmaceuticals Ltd | 0.73% |
| Piramal Pharma Ltd | 0.63% |
| Global Health Ltd | 0.62% |
| Regeneron Pharmaceuticals Inc | 0.58% |
| Syngene International Ltd | 0.52% |
| Becton Dickinson & Co | 0.36% |
| Agilent Technologies Inc | 0.24% |
| IQVIA Holdings Inc | 0.21% |
| Illumina Inc | 0.14% |
| Net Receivables/(Payables) | 0.17% |
| Clearing Corporation Of India Ltd. | 0.15% |
| Accrued Interest | 0.00% |
In which sectors has Edelweiss MSCI India D&W HC 45 RegIDCW-T invested in?
The Edelweiss MSCI India D&W HC 45 RegIDCW-T has invested the majority of its money in the stocks of the following sectors -
| Company | Percentage of Portfolio |
|---|---|
| Basic Materials | - |
| Communication Services | - |
| Consumer Cyclical | - |
| Consumer Defensive | - |
| Energy | - |
| Financial Services | - |
| Healthcare | 99.68% |
| Industrials | - |
| Real Estate | - |
| Technology | - |
| Utilities | - |
What is the risk level of Edelweiss MSCI India D&W HC 45 RegIDCW-T?
This is a Index Funds fund comes with Very High Risk.
Who are the fund managers of Edelweiss MSCI India D&W HC 45 RegIDCW-T?
Edelweiss MSCI India D&W HC 45 RegIDCW-T fund managers are Bhavesh Jain, Amit Vora.
Is there a minimum SIP amount to invest in Edelweiss MSCI India D&W HC 45 RegIDCW-T?
The minimum SIP amount to start investment in Edelweiss MSCI India D&W HC 45 RegIDCW-T is ₹100 while ₹1,000 can be invested as Lumpsum amount.
Can I invest in Edelweiss MSCI India D&W HC 45 RegIDCW-T both in SIP and lump sum?
You can opt for either SIP or Lumpsum to invest in Edelweiss MSCI India D&W HC 45 RegIDCW-T on the basis of your investment objective and risk tolerance.
How to invest in Edelweiss MSCI India D&W HC 45 RegIDCW-T?
Investing in mutual funds is easy on HDFC SKY.
Follow these simple steps to invest in Edelweiss MSCI India D&W HC 45 RegIDCW-T:
- On HDFC SKY open your demat account if you don't have one.
- Check the performance of Edelweiss MSCI India D&W HC 45 RegIDCW-T.
- Choose between SIP or Lumpsum and start your mutual fund investment journey on HDFC Sky.
Is there any exit load charges of Edelweiss MSCI India D&W HC 45 RegIDCW-T?
The exit load of Edelweiss MSCI India D&W HC 45 RegIDCW-T is as follows:
Exit load of 0.0%, if redeemed within 1 year
.What is the process to redeem my investment in HDFC SKY?
The following are the Steps to Redeem mutual funds on HDFC SKY:
1. Go to Mutual Funds > My Investments/Portfolio.
2. Select the fund and tap Redeem/Sell.
3. Choose Full, Units, or Amount.
4. Review NAV, units, and exit load.
5. Confirm. Amount (Units × NAV) is credited to the registered bank in T+1–T+3 days. ELSS has a 3-year lock-in.
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy